What sector is EDGE in?

Healthcare, in the Pharmaceuticals industry.

Cboe BZX · EDGEHealthcarePharmaceuticals

MRBL Enhanced Equity ETF (EDGE)

$51.44−0.44%

Close Nov 12, 2026 · split-adjusted

Nov 12, 2026$51.78▲ 16.25% in range

Nov 12, 2025Low $42.20 · High $52.91Nov 12, 2026

What changed · written from our data

As of Nov 12, 2026

MRBL Enhanced Equity ETF closed at $51.44 on Nov 12, down 0.44%, 2.8% below its 52-week closing high. Volume of 894 shares was 0.69× its 20-day average (below normal).

Split-adjusted performance: -1.6% over one month, +5.4% over six months, +15.5% over one year.

Short interest was 18 shares at the Oct 30 settlement, down 99.8% from the prior report (1.0 days to cover).

Market cap—

Revenue · quarter$0.00—

Diluted EPS$-0.18—

P/E · TTM—

Net margin—

Dividend yieldNone

52-week range42.20 – 52.91−2.8% from high

Volume8940.69× 20-day avg

Volatility · 60d16.6%Annualised

Short % of float—1.0 days to cover

Net cash$1.2MCash $5.6M

Next earnings—Not scheduled

Split-adjusted performance

1W +3.9%1M −1.6%3M −1.0%6M +5.4%YTD +13.3%1Y +15.5%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 419 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −26.6%, revenue growth +10.0%, net margin −36.2%, P/E 17.1×.

Short interest

Details →

Shares short18−99.8% vs prior

Days to cover1.0Settled Oct 30

% of float—

Short vol. 10d55.6%of daily volume

News about MRBL Enhanced Equity ETF

All news →

Enhanced Equity ETF (EDGE) Touches New 52-Week HighZacks Investment Research · Oct 13, 2026▲ Positive

Quick answers

What sector is EDGE in?: Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology